BioSpace

OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia

The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies based on the Eastern continent.

By BioSpace

1 min read
OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights